Save travels and welcome to Europe.
10.10.2025 11:54 — 👍 0 🔁 0 💬 0 📌 0@stf-orm.bsky.social
professor of pathology @i-med.ac.at focussing on #PancreaticCancer, #gastrointestinalPathology, #molecularDiagnostics and #oncology. bike commuter. part time cancer researcher. Enjoying our alpine surroundings on board, bike, foot and skis.
Save travels and welcome to Europe.
10.10.2025 11:54 — 👍 0 🔁 0 💬 0 📌 0This lesion here has the classic morphology of a traditional serrated adenoma and the typical BRAF-V600E-mutation. Note the non-neoplastic colonic crypts in the middle, which are negative for BRAF-V600E.
07.10.2025 11:33 — 👍 0 🔁 0 💬 0 📌 0Pathology integrates the morphology of a lesion and its molecular alterations to come to definite diagnosis in the best case and to guide a patient's therapy, often in the oncological setting.
07.10.2025 11:31 — 👍 0 🔁 0 💬 1 📌 0Shouldn't that be far more than enough for a soccer World cup in the USA? Under the current regime and the current conditions very few spectators from other, way more soccer-crazy countries will make it to the US, especially from latin America and Europe.
26.09.2025 14:14 — 👍 0 🔁 0 💬 0 📌 0Congrats to our resident Michael Günther! He was awarded this year's G. Tiniakos award for best oral presentation at ESP congress Vienna.
Well deserved! 💪🏼 @i-med.ac.at @dinatiniakos.bsky.social
Estamos aquí para apoyar a pacientes y familias. 💜 Aprenda más ➡️ pancan.org/es
22.09.2025 23:00 — 👍 1 🔁 1 💬 0 📌 0.
THIS is one of the biggest problems of our time . . .
⬇️ ⬇️ ⬇️
.
@i-med.ac.at @eurpancreaticclub.bsky.social Pancreas2000 meeting in Istanbul was a blast! Our resident Michael Günther presenting a Pancreas2000 project on sex differences in #PDAC treatment.
31.08.2025 10:03 — 👍 0 🔁 0 💬 0 📌 0You can't teach U.S. history without "divisive" narratives. Slavery wasn't "unifying." The Japanese incarceration wasn't "unifying." The anti-immigrant Operation Wetback (real name) wasn't "unifying."
It's history's job to tell the truth, not cover up past racism to pave the way for future racism.
Die Leute, die 800 Euro pro Stunde verdienen, haben die Leute, die 80 Euro pro Stunde verdienen, davon überzeugt, dass die Leute, die 13 Euro pro Stunde verdienen, das Problem sind.
28.07.2025 06:18 — 👍 2724 🔁 880 💬 39 📌 13Jetzt auch in der deutschen Presselandschaft angekommen...
www.aerzteblatt.de/news/antibio...
Hier der Text des Aufrufs von ca 300 Rechtswissenschaftlerinnen und Rechtswissenschaftlern, darunter ehemalige Mitglieder des Bundesverfassungsgerichts. www.oer.ruhr-uni-bochum.de/oer/mam/cont...
14.07.2025 19:58 — 👍 347 🔁 111 💬 13 📌 10🔝 PatientInnen mit Bauchspeicheldrüsenkrebs überlebten doppelt so lang, wenn sie nach der OP zur Chemotherapie mit Gemcitabin ein Antibiotikum erhielten. 👉 Wichtige Ergebnisse von @stf-orm.bsky.social und Team. Weitere Studien sind geplant.
#meduniibk
Dr O'Reilly on the Rapidly Evolving Role of Local Therapy in Metastatic Pancreatic Cancer - goo.gl/alerts/RfGamU #GoogleAlerts
04.07.2025 11:50 — 👍 0 🔁 1 💬 0 📌 0"Die Hitzewelle zu verhindern wäre undemokratisch. Wir müssen die Dürre inhaltlich stellen ☝️😏"
01.07.2025 19:15 — 👍 2026 🔁 391 💬 53 📌 20Thank you for sharing our article! ❤️
12.06.2025 15:57 — 👍 1 🔁 0 💬 0 📌 0I want to thank my whole team for their excellent work on these papers and our collaborators for their support! @i-med.ac.at
10.06.2025 20:25 — 👍 2 🔁 0 💬 0 📌 0in patients treated with adjuvant gemcitabine-based therapies. Even cases with high abundance+postopABT had a similar outcome as cases with low abundance and no ABT. Thus postoperative ABT shortly before adjuvant gemcitabine-based chemotherapy may serve as additive therapy. tinyurl.com/3htdnwdk
10.06.2025 20:21 — 👍 1 🔁 0 💬 0 📌 0As one thinks about detrimental bacteria, one may instantly think about how to fight them, possibly by antibiotics (ABT). We determined how perioperative ABT affected patient outcome in the adjuvant situation. Surprisingly, only postoperative but not preoperative ABT improved the patients' prognosis
10.06.2025 20:14 — 👍 1 🔁 0 💬 0 📌 0Thus we reasoned that it is not necessarily the bacterial composition but rather the bacterial abundance within a tumor which determines its response to gemcitabine as high abundances invariably come with high amounts of gemcitabine-degrading bacteria.
10.06.2025 20:09 — 👍 1 🔁 0 💬 0 📌 0Finally, we sought to determine the role of gram-positive bacteria in this context as they may degrade gemcitabine, but with lower efficacy. Thus, we detected bacterial lipoteichoic acid (LTA), a surface marker of gram-positive bacteria in FFPE tumor samples and it resembled what we saw with LPS.
10.06.2025 20:02 — 👍 1 🔁 0 💬 0 📌 0This was the case for advanced PDAC tinyurl.com/yc6799rv but also for the adjuvant situation tinyurl.com/9sryx225.
By 16s rRNA sequencing on a subset of samples, we found that LPS positivity defined a specific intratumoral microbiome enriched for bacteria capable of gemcitabine degradation.
Indeed, not only did we find LPS in a good proportion of PDAC samples, we could also show that patients with LPS- positive tumors had a much worse outcome when treated with gemcitabine-based chemotherapy.
10.06.2025 19:51 — 👍 1 🔁 0 💬 0 📌 0We then sought to determine whether 1. There were intratumoral bacteria in archival PDAC samples and 2. how they affected patient outcome. We focused on bacterial lipopolysaccharide (LPS), a marker of gram-negative bacteria detectable by immunohistochemistry(IHC).
10.06.2025 19:45 — 👍 1 🔁 0 💬 0 📌 0First, Geller et al. described the role of gram-negative bacteria within PDAC tumors tinyurl.com/487v65df
A finding which had previously been published, though a bit less prominent www.nature.com/articles/sre....
I would like to tell a little tale about our view on the microbiomes' implications in pancreatic cancer.
As pathologists, we mostly focus on the tumor tissue itself, not on non-neoplastic tissue afar from the tumor. Thus, we focus on the intratumoral microbiomes and its meaning for patient outcome.
Die Innpath der Tirol Kliniken / Allgemeine Pathologie der @i-med.ac.at ist auf der AustroDoc in Innsbruck vertreten! Komm vorbei und informier dich über die Möglichkeiten unseres Faches!
#pathology
🚨 From @ascocancer.bsky.social 2025
👉 Preop chemo with PAXG 🆚 mFOLFIRINOX for extending event-free survival (EFS) in resectable or BR PDAC (phase 3 CASSANDRA trial)
🆙 PAXG 3-year EFS 31% vs. 13% P = .003
🫸 Immature analysis for survival but.. future practice changing?! 🧐
@ascopost.bsky.social
Author conclusions #ASCO25
01.06.2025 18:15 — 👍 1 🔁 1 💬 0 📌 0Die Pathologie der Tirol Kliniken und der Medizinischen Universität Innsbruck sind bei der AustroDoc am 3.6. in Innsbruck vertreten.
Komm vorbei und informier dich über die Perspektiven und Möglichkeiten unseres Faches!
@i-med.ac.at